Answers are grounded in this paper and cite their sources.
Phosphatidic acid phosphatases (PAPs) regulate lipid metabolism by controlling the interconversion of phosphatidic acid (PA) and diacylglycerol (DAG), thereby influencing membrane composition and multiple downstream cellular processes. We investigated the role of PAP2-2 in Leishmania mexicana using CRISPR-Cas9-mediated gene ablation and genetic complementation. Immunofluorescence analyses revealed partial co-localization of PAP2-2 with the endoplasmic reticulum. Ablation of the PAP2-2-encoding gene Lmx M.19.1350 significantly reduced total phosphatidic acid phosphatase activity, resulting in marked accumulation of endogenous PA and alterations in lipid composition, including changes in phosphatidylcholine, cardiolipin, sterols, and selected DAG species. PAP2-2-deficient parasites displayed altered cell morphology, reduced growth, and delayed differentiation into metacyclic promastigotes and amastigotes. Furthermore, loss of PAP2-2 impaired mitochondrial physiology, as evidenced by reduced basal respiration, diminished oxidative phosphorylation capacity, altered electron transport chain activities, and decreased responsiveness to respiratory substrates and inhibitors. Our findings identify PAP2-2 as an important regulator of PA/DAG homeostasis in L. mexicana and demonstrate that disruption of this enzyme triggers extensive lipid remodeling with downstream effects on mitochondrial function, parasite development, and cellular morphology. These results highlight the central role of membrane lipid homeostasis in the physiology of Leishmania and establish PAP2-2 as a previously underappreciated determinant of parasite fitness that may represent a promising target for future mechanistic and therapeutic investigations.
No takes yet. Share an insight, caveat, or question.
Kalita et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: